Insider Transactions in Q2 2025 at An2 Therapeutics, Inc. (ANTX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2025
|
Eric Easom Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+3.75%
|
$10,000
$1.07 P/Share
|
|
May 30
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
432,000
-5.93%
|
$432,000
$1.02 P/Share
|
|
May 28
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
2,300,000
-14.56%
|
$2,300,000
$1.14 P/Share
|
|
May 28
2025
|
Margaret M Fitz Patrick |
BUY
Open market or private purchase
|
Direct |
8,610
+50.0%
|
$8,610
$1.18 P/Share
|
|
Apr 10
2025
|
Patricia A. Martin |
BUY
Grant, award, or other acquisition
|
Direct |
3,065
+32.97%
|
-
|
|
Apr 10
2025
|
Joseph S Zakrzewski |
BUY
Grant, award, or other acquisition
|
Direct |
10,523
+6.74%
|
-
|
|
Apr 10
2025
|
Gilbert Lynn Marks |
BUY
Grant, award, or other acquisition
|
Direct |
9,705
+18.95%
|
-
|
|
Apr 10
2025
|
Kabeer Aziz |
BUY
Grant, award, or other acquisition
|
Direct |
9,705
+34.19%
|
-
|